GALLIVANONE, FRANCESCA
 Distribuzione geografica
Continente #
AS - Asia 2.202
NA - Nord America 1.864
EU - Europa 582
SA - Sud America 403
Continente sconosciuto - Info sul continente non disponibili 79
AF - Africa 51
OC - Oceania 6
Totale 5.187
Nazione #
US - Stati Uniti d'America 1.759
SG - Singapore 915
CN - Cina 428
BR - Brasile 316
HK - Hong Kong 240
VN - Vietnam 218
IT - Italia 212
FR - Francia 130
KR - Corea 86
BD - Bangladesh 81
JP - Giappone 62
GB - Regno Unito 50
CA - Canada 48
IN - India 40
NL - Olanda 34
FI - Finlandia 30
DE - Germania 29
ID - Indonesia 24
EC - Ecuador 20
MX - Messico 20
AR - Argentina 19
CO - Colombia 17
IQ - Iraq 16
TR - Turchia 16
CR - Costa Rica 12
ZA - Sudafrica 12
IL - Israele 11
RU - Federazione Russa 11
VE - Venezuela 11
CL - Cile 10
UA - Ucraina 10
ES - Italia 9
JM - Giamaica 9
AT - Austria 8
EG - Egitto 8
PK - Pakistan 8
MA - Marocco 7
PH - Filippine 7
MY - Malesia 6
UZ - Uzbekistan 6
AE - Emirati Arabi Uniti 5
IE - Irlanda 5
KE - Kenya 5
PT - Portogallo 5
PY - Paraguay 5
SA - Arabia Saudita 5
SC - Seychelles 5
AU - Australia 4
CH - Svizzera 4
DK - Danimarca 4
EE - Estonia 4
JO - Giordania 4
KG - Kirghizistan 4
KZ - Kazakistan 4
PL - Polonia 4
RS - Serbia 4
SV - El Salvador 4
AL - Albania 3
BB - Barbados 3
GR - Grecia 3
HU - Ungheria 3
LT - Lituania 3
SI - Slovenia 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BE - Belgio 2
BH - Bahrain 2
BO - Bolivia 2
ET - Etiopia 2
GE - Georgia 2
LV - Lettonia 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
PA - Panama 2
RO - Romania 2
SE - Svezia 2
SN - Senegal 2
TH - Thailandia 2
UY - Uruguay 2
ZM - Zambia 2
AO - Angola 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BY - Bielorussia 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GD - Grenada 1
GH - Ghana 1
GT - Guatemala 1
HN - Honduras 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
ML - Mali 1
MT - Malta 1
NG - Nigeria 1
NP - Nepal 1
PE - Perù 1
PS - Palestinian Territory 1
Totale 5.102
Città #
Santa Clara 680
Singapore 524
Hong Kong 236
San Jose 173
Hefei 166
Ashburn 110
Beijing 94
Lauterbourg 91
Seoul 84
Ho Chi Minh City 83
Los Angeles 66
Tokyo 50
Hanoi 37
New York 36
São Paulo 33
Milan 29
Dallas 25
Buffalo 24
Rome 17
Rio de Janeiro 14
Brooklyn 13
Helsinki 13
Montreal 13
Phoenix 13
Brescia 11
Da Nang 11
Istanbul 11
Council Bluffs 10
Johannesburg 10
Lappeenranta 10
Las Vegas 10
Baghdad 9
Bari 9
Houston 9
Manchester 9
Minamishinagawa 9
Quito 9
San José 9
Toronto 9
Chennai 8
Denver 8
Guangzhou 8
Guayaquil 8
Haiphong 8
Naples 8
Newark 8
Nuremberg 8
Curitiba 7
Indianapolis 7
Orem 7
Paris 7
Philadelphia 7
Atlanta 6
Boardman 6
Bogotá 6
Chicago 6
Dublin 6
Florence 6
Frankfurt am Main 6
Guarulhos 6
Jakarta 6
London 6
Poplar 6
Porto Alegre 6
Tashkent 6
Thái Nguyên 6
Turin 6
Turku 6
Amsterdam 5
Arese 5
Belo Horizonte 5
Bengaluru 5
Birmingham 5
Bologna 5
Detroit 5
Dhaka 5
Hải Dương 5
Kingston 5
Kyiv 5
Louisville 5
Mexico City 5
Munich 5
Padua 5
Pisa 5
Seattle 5
Washington 5
Amman 4
Belgrade 4
Bishkek 4
Biên Hòa 4
Boston 4
Buenos Aires 4
Charlotte 4
Düsseldorf 4
Lucca 4
Marseille 4
Monza 4
Mumbai 4
Nairobi 4
Quận Một 4
Totale 3.110
Nome #
Assessing Spectral Metrics to Estimate Aquatic Plant Diversity from Hyperspectral Imaging: Preliminary Results 138
Exploring spectral and phylogenetic diversity links with functional structure of aquatic plant communities 118
Acute Inescapable Stress Rapidly Increases Synaptic Energy Metabolism in Prefrontal Cortex and Alters Working Memory Performance. 98
AI applications to medical images: From machine learning to deep learning 89
Estimating Aquatic Plant Diversity Using Spectral Metrics from Drone Hyperspectral Imaging 81
Statistical voxel-based analysis of [F-18]FDG PET animal studies for the estimation of glucose metabolism in stress conditions 80
Bioinformatics clouds for high-throughput technologies 79
Circulating microRNAs as Potential Novel Diagnostic Biomarkers to Predict Drug Resistance in Temporal Lobe Epilepsy: A Pilot Study 78
Influence of canopy structure and illumination geometry on spectral anisotropy of aquatic vegetation in ultra-high resolution hyperspectral imagery 78
Targeted radionuclide therapy: frontiers in theranostics 75
Relationship between 18F-FDG PET SUV with Partial Volume Correction and Histology in Gastric and Gastro-Oesophageal Cancer 73
Impact of Radiometric Variability on Ultra-High Resolution Hyperspectral Imagery Over Aquatic Vegetation: Preliminary Results 73
Correlation between 18FDG PET SUV with Partial Volume Correction and MRS Choline signal integral in breast cancer 70
Clinical assessment of a recovery coefficients-based partial volume correction in 18F-FDG PET-CT oncological studies 62
Agarose/Sucrose Gel Breast Phantom for Validation of Quantitative Methods in Diffusion Weighted Imaging 62
Characterization of cell cycle, inflammation, and oxidative stress signaling role in non-communicable diseases: Insights into genetic variants, microRNAs and pathways 62
A Standardized [18F]-FDG-PET Template for Spatial Normalization in Statistical Parametric Mapping of Dementia 62
PET-CT FDG quantification of oncological lesions: a PVE correction method from measured L/B and lesion volume 61
Radiogenomics, Breast Cancer Diagnosis and Characterization: Current Status and Future Directions 61
Prognostic Value of pre-therapy 18FDG PET/CT for the Outcome of 18FDG PET-guided SIB-IMRT in Patients with Head and Neck Cancer 61
A tri-modal tissue-equivalent anthropomorphic phantom for PET, CT and multi-parametric MRI radiomics 61
18F-FDG PET/CT in gastro-oesophageal cancer: correlations between Partial Volume Corrected Body-Weight Standardized Uptake Value (PVC-SUVBW) and biological characteristics of primitives 59
Radiomics and gene expression profile to characterise the disease and predict outcome in patients with lung cancer 58
Effects of functional type and angular configuration on reflectance anisotropy of aquatic vegetation in ultra-high resolution hyperspectral imagery 56
Serum MicroRNAs as Predictors of Diagnosis and Drug-resistance in Temporal Lobe Epilepsy: A Preliminary Study 56
Machine Learning on Brain MRI Data for Differential Diagnosis of Parkinson's Disease and Progressive Supranuclear Palsy 55
Secreted miR‐153 Controls Proliferation and Invasion of Higher Gleason Score Prostate Cancer 54
Prognostic value of pre-therapy 18F-FDG PET/CT for the outcome of radiotherapy treatment in patients with head and neck cancer 53
Statistical Voxel-Based Methods and [18F]FDG PET Brain Imaging: Frontiers for the Diagnosis of AD 53
Pet/mri for staging the axilla in breast cancer: Current evidence and the rationale for snb vs. pet/mri trials 53
Advanced Imaging Analysis in Prostate MRI: Building a Radiomic Signature to Predict Tumor Aggressiveness 53
The impact of different 18FDG PET Healthy Subject scans for comparison with single patient in SPM analysis. 52
statistical parametric mapping for activations studies in rats 50
Partial volume corrected 18F-FDG PET mean standardized uptake value correlates with prognostic factors in breast cancer. 50
Quantitation and data analysis in hybrid PET/MRI systems 50
AI-based applications in hybrid imaging: how to build smart and truly multi-parametric decision models for radiomics 49
A Partial Volume Effect Correction Tailored for (18)F-FDG-PET Oncological Studies 49
[18F]FDG PET/MRI vs sentinel node biopsy for axillary staging of early breast cancer patients. A prospective single-arm trial 49
Predictive value of pre-therapy 18F-FDG PET/CT for the outcome of 18F-FDG PET-guided radiotherapy in patients with head and neck cancer 48
A Graph-Based Method for PET Image Segmentation in Radiotherapy Planning: A Pilot Study 47
Prognostic value of quantitative 18F-FDG PET biomarkers in breast cancer 47
Statistical voxel-based analysis of [18F]FDG PET animal studies for the estimation of glucose metabolism in stress conditions 47
Parameters influencing PET imaging features: A phantom study with irregular and heterogeneous synthetic lesions 46
A graph-based method for biological target volume segmentation 46
Partial volume corrected 18F-FDG PET mean standardized uptake value correlates with prognostic factors in breast cancer. 45
Metabolic impact of partial volume correction of [18F]FDG PET-CT oncological studies on the assessment of tumor response to treatment. 45
An anthropomorphic phantom for advanced image processing of realistic 18F-FDG PET-CT oncological studies 44
18F-FDG PET as a tool for imaging proliferation in breast cancer: correlation between partial volume-corrected SUV and MIB-1 proliferation index 43
Imaging Imagination 43
A method for manufacturing oncological phantoms for the quantification of 18F-FDG PET and DW-MRI studies 43
Response to chemotherapy in gastric adenocarcinoma with diffusion-weighted MRI and 18 F-FDG-PET/CT: Correlation of apparent diffusion coefficient and partial volume corrected standardized uptake value with histological tumor regression grade 42
Acute stress studies in rats by 18FDG PET and SPM 42
Touch-SUV (Licenza Software) 42
18F-FDG PET/CT in gastro-oesophageal cancer: correlations between Partial Volume Corrected Body-Weight Standardized between Partial Volume Corrected Body-Weight Standardized primitives 42
Validity of cingulate-precuneus-temporo-parietal hypometabolism for single-subject diagnosis of biomarker-proven atypical variants of Alzheimer's Disease 42
Prospective comparison of MR with diffusion-weighted imaging, Endoscopic Ultrasound, MDCT and Positron Emission Tomography-CT in the preoperative staging of oesophageal cancer: results from a pilot study. 42
The utility of FDG-PET in the differential diagnosis of Parkinsonism 41
PVE correction in PET-CT whole-body oncological studies from PVE-affected images 41
Statistical Voxel-Based Methods and [18F]FDG PET Brain Imaging: Frontiers for the Diagnosis of AD 41
E-Health Decision Support Systems for the Diagnosis of Dementia Diseases 41
Integration of in vivo biomarkers with ex vivo histo-pathological and immune-histochemical data: the effect of Partial Volume Correction on PET studies. 41
Validation of normal control database from different CT-PET scanners for SPM single-subject analysis of 18FDG PET brain images 41
Quantitative measurement of 18F-FDG PET/CT uptake reflects the expansion of circulating plasmablasts in IgG4-related disease 40
Imaging of proliferation in breast cancer with 18F-FDG PET: Correlation between partial volume corrected SUV and MiB-1 proliferation index 39
18F-FDG relationship with histopathological and immunohistochemical data in breast cancer using SUV with or without Partial Volume Correction 39
Correlation between 18FDG PET SUV with Partial Volume Correction and MRS Choline signal integral in breast cancer 38
18F-FDG PET in gastro-oesophageal cancer: clinical impact of Partial Volume Correction in treatment monitoring 37
Integration of quantitative biomarkers from in vivo multi-modal PET and MR studies for the diagnostic and therapeutic management of Gastric Cancer patients 37
Touchscreen-technology-assisted method for diagnostic reporting of quantitative CT-PET oncology studies 37
Clinical validation of a Grid-based SPM web tool for the automatic assessment of [18F]FDG-PET brain metabolic automatic assessment of [18F]FDG-PET brain metabolic 37
Adaptive threshold method based on PET measured lesion-to-background ratio for the estimation of Metabolic Target Volume from F-18-FDG PET images 37
Biomarkers from in vivo molecular imaging of breast cancer: pretreatment F-FDG PET predicts patient prognosis, and pretreatment DWI-MR predicts response to neoadjuvant chemotherapy. 37
One-year-experience in the use of Partial Volume Correction impact on the role of 18FDG PET for the diagnosis, prognosis and therapy monitoring toward personalized medicine in oncology 37
Clinical assessment of a recovery coefficients based partial volume correction method: impact on SUV quantification of bone metastases in 18F-FDG PET-TC studies 36
Radiomics‐Based Prognostication in Primary Sclerosing Cholangitis: A Proof‐of‐Concept Study 36
FDG PET/CT as theranostic imaging in diagnosis of non-small cell lung cancer 35
A virtual lab of integrated molecular medicine 35
Prognostic Value of 18F-Fluorocholine PET Parameters in Metastatic Castrate-Resistant Prostate Cancer Patients Treated with Docetaxel. 35
An automatic segmentation method for the measurement of the functional volume of oncological lesions on MR ADC maps 35
A Clinical feasible, Operator Indipendent Partial Volume Correction for Oncological 18F-FDG PET-CT studies 35
cOuch (Licenza Software) 34
Accuracy, reproducibility, feasibility and clinical impact of a PVC on 18F-FDG quantification in bone metastases by PET/CT follow-up studies 33
New positron emission tomography derived parameters as predictive factors for recurrence in resected stage I non-small cell lung cancer 33
Hybrid PET/MRI for in Vivo imaging of cancer: Current clinical experiences and recent advances 33
Feasibility and clinical impact of an Operator Independent quantification method in 18F-FDG PET/CT oncological studies. 33
FP7-Eu project DECIDE (Diagnostic Enhancement of Confidence by an International Distributed Environment): e-services for the assisted diagnosis of neurodegenerative functional studies 33
A Decision Support System for the assisted diagnosis of brain tumors: a feasibility study for F-18-FDG PET preclinical studies 32
e-services for image-based diagnosis of neurodegenerative diseases 32
PVE correction in PET from PVE affected images. 32
STRAT 32
A clinically feasible, Operator Indipendent Partial Volume Correction for oncological 18F-FDG PET-TC studies 32
Quantification of PET-CT 18F-FDG oncological lesions with Partial Volume Effect correction 32
A Decision Support System for the assisted diagnosis of brain tumors: A feasibility study for (18)F-FDG PET preclinical studies. 32
[18F]FDG PET/CT features for the molecular characterization of primary breast tumors 31
A tool for the extraction of new disease biomarkers from ex vivo and in vivo data 31
A clinically feasible, Operator Independent Partial Volume Correction for oncological 18F-FDG PET-CT studies 31
Feasibility of supervised machine learning technique for assisted diagnosis of cancer: application to PET studies in small animals. 30
FP7-Eu project DECIDE (Diagnostic Enhancement of Confidence by an International Distributed Environment): e-services for the assisted diagnosis of neurodegenerative diseases. 30
Partial Volume Correction Methods Based on Measured Lesion-to-Background Ratio in PET-CT Oncological Studies. 29
An e-infrastructure for integrating translational molecular medicine. 29
Totale 4.859
Categoria #
all - tutte 16.812
article - articoli 11.472
book - libri 180
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 491
Totale 28.955


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202437 0 0 0 0 0 0 0 0 4 0 33 0
2024/20251.854 6 8 128 57 570 117 34 113 38 38 407 338
2025/20262.730 138 183 232 388 516 161 398 103 145 202 168 96
2026/2027566 175 136 255 0 0 0 0 0 0 0 0 0
Totale 5.187